Protagonist Therapeutics, Inc — Director's Dealing 2021

Feb 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2021-02-26

Reporting Person: Kalkofen Donald A. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-26	Common Stock	A	7500	$0.00	Acquired	10386	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-26	Stock Option (right to buy)	$23.57	A	55000	Acquired	2031-02-25	Common Stock (55000)	Direct

Footnotes

F1: Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024.

F2: Includes an aggregate of 1,711 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2020 and September 9, 2020.

F3: The stock option vests in 48 equal monthly installments following the date of grant.